New Medicine, Pharmaceuticals & Biotechnology Research Reports Recently Published by

15 Nov 2011 • by Natalie Aster
New Medicine, Pharmaceuticals & Biotechnology Research Reports Recently Published by

LONDON - Market Publishers Ltd informs that new in-demand GBI Research reports on medicine, pharmaceuticals & biotechnology markets and markets issues have been added to its catalogue.

Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge. The report presents a granular study of the healthcare systems and roles of the key players in the respective pharmaceutical systems of 12 European nations with a detailed analysis of the different regulatory mechanisms used in these countries.  The study thoroughly examines the major changes in the pharmaceuticals related pricing and reimbursement in these European nations in the recent past and their impact in the near future …

Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology. The review gives true insights into the patient recruitment status by geography, by Sponsor Company and by year for all the major orphan diseases in CNS and oncology. The report also compares the clinical trials and patient recruitment in orphan diseases with other diseases in CNS and oncology. Besides, profiles of prevalence forecast data through 2017 for all the major indications are also provided …

Dental Device Market to 2017 - CAD/CAM and Minimal Invasive Cosmetic Dentistry to Drive the Market. The research offers a comprehensive guide into the world dental devices market, covering its seven categories. The study features the key trends affecting these categories, as well as the market dynamics. Elaborate information on the top market players, the competitive landscape, and the leading technologies is also available …

Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues. The warning letters and drug recalls have significantly increased during 2007-2010 due to various underlying causes. The study features in-depth analysis of warning letters, drug recalls issued or reported with the U.S. Food and Drug Administration (FDA) and its constituent agencies. Detailed analysis of recalled products, with the year of recall, recalling firm, dosage form, therapy area, reason for recall and the subset reason for recalls, is provided …

More new research reports by the publisher can be found at GBI Research page.



The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 123 2220

Fax: +44 207 900 3970